LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 27 filers reported holding LANTERN PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $324,141 | -36.2% | 95,036 | +5.6% | 0.00% | – |
| Q2 2023 | $507,746 | +82.0% | 90,026 | +55.8% | 0.00% | – |
| Q1 2023 | $279,048 | +80086.2% | 57,774 | 0.0% | 0.00% | – |
| Q4 2022 | $348 | -99.9% | 57,774 | -0.2% | 0.00% | – |
| Q3 2022 | $276,000 | -15.9% | 57,909 | +0.6% | 0.00% | – |
| Q2 2022 | $328,000 | -19.4% | 57,564 | +0.9% | 0.00% | – |
| Q1 2022 | $407,000 | -10.5% | 57,043 | 0.0% | 0.00% | – |
| Q4 2021 | $455,000 | -28.6% | 57,043 | 0.0% | 0.00% | – |
| Q3 2021 | $637,000 | -21.3% | 57,043 | +2.8% | 0.00% | – |
| Q2 2021 | $809,000 | -2.6% | 55,479 | +21.1% | 0.00% | – |
| Q1 2021 | $831,000 | – | 45,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |